Sandoz

News

Sandoz will pay another $480m to settle US antitrust suits

Sandoz has reached a settlement in the US that, if approved, could lay to rest years of litigation over price-fixing of generic medicines.

News

Trump sets course for 100%, then 200%, tariffs on generics

Trump has said he intends to impose tariffs of 100% on generic drugs imported into the US from 2028, rising to 200% after a year, in a reshoring push.

Patients

pharmaphorum podcast Episode 263, Rebecca Guntern - Sandoz

Biosimilars & patient access independent of geographies or s...

Rebecca Guntern, Sandoz' CCO, discusses the ‘golden decade’ for generics and biosimilars as so many blockbuster drugs come off patent.

News

A pregnant woman with her hands forming a heart shape over her bump, wearing a beige sweater

NICE recommends wider use of MS drug natalizumab via NHS

NICE has backed NHS use of natalizumab, a key treatment option that is safe for use in pregnancy, for more patients with multiple sclerosis.

Market Access

Inside Sandoz: How women leaders are driving sustainability ...

News

Sandoz launches first biosimilar Tysabri in US

Biogen is facing biosimilar competition to its multiple sclerosis therapy Tysabri in the US for the first time, as Sandoz enters the market.

Sandoz will pay another $480m to settle US antitrust suits

Trump sets course for 100%, then 200%, tariffs on generics

Biosimilars & patient access independent of geographies or s...

NICE recommends wider use of MS drug natalizumab via NHS

Inside Sandoz: How women leaders are driving sustainability ...

Sandoz launches first biosimilar Tysabri in US

TransThera's resistant biliary cancer drug cleared in China

Discover a new era of healthcare panel engagement: Grounded ...

Sandoz

Editor's Picks